Skyrizi® (Risankizumab-rzaa) IV Infusion Therapy in Miami

Advanced Biologic Therapy for Plaque Psoriasis and Crohn’s Disease

Clearwell Infusion Centers offers Skyrizi IV infusion therapy for adults managing moderate to severe plaque psoriasis and Crohn’s disease. Located in Miami, our outpatient infusion center features private suites, personalized care, and convenient scheduling—delivering treatment in a calm, patient-focused environment.

What Is Skyrizi?

Skyrizi® (risankizumab-rzaa) is an FDA-approved monoclonal antibody that targets interleukin-23 (IL-23), a key cytokine involved in chronic inflammation. By blocking IL-23, Skyrizi helps reduce immune system overactivity that contributes to skin and gastrointestinal symptoms.

Skyrizi is administered as a short IV infusion for induction, followed by maintenance subcutaneous injections.

Learn more at the official Skyrizi website.

Conditions Treated with Skyrizi

Skyrizi is indicated for the treatment of:

• Moderate to Severe Plaque Psoriasis
• Active Psoriatic Arthritis
• Moderately to Severely Active Crohn’s Disease

In Crohn’s disease, Skyrizi is given as a 3-dose IV induction regimen over the first 6 weeks, then continued as a maintenance injection every 8 weeks.

Skyrizi Side Effects

Skyrizi is generally well tolerated, but some patients may experience:

• Upper respiratory infections
• Headache or fatigue
• Injection site or infusion-related reactions
• Nausea
• Increased risk of infection

Clearwell’s experienced nursing team monitors every infusion carefully using ACHC-accredited protocols to ensure your safety and comfort.

For full safety information, see the Skyrizi prescribing information.

Why Choose Clearwell for Your Skyrizi Infusion?

Clearwell Infusion Centers makes starting and continuing your Skyrizi treatment as smooth and stress-free as possible. When you choose Clearwell, you benefit from:

• Private treatment suites with spa-like amenities
• Low patient-to-nurse ratio for attentive care
• Flexible appointment times, including weekends and evenings
• Comprehensive insurance coordination, including prior authorizations and benefits checks
• ACHC-accredited facility and safety standards
• Close coordination with your prescribing provider and care team

Skyrizi infusions typically last approximately 1 hour and are given on Weeks 0, 4, and 8 for induction in Crohn’s disease.

Getting Started with Skyrizi

If your dermatologist or gastroenterologist has prescribed Skyrizi, we’ll coordinate all aspects of your care—verifying insurance, scheduling treatments, and maintaining communication with your care team.

Questions? Call 305‑306‑7147 or email contact@clearwellinfusion.com.

Referring Providers: Partner with Clearwell Infusion Centers

Clearwell Infusion Centers partners with dermatologists and gastroenterologists across South Florida to safely administer Skyrizi IV induction therapy in a professional outpatient setting.

Why refer to Clearwell?

• Fast turnaround on benefit verification and prior authorizations
• Streamlined referral and scheduling process
• Secure, timely infusion documentation shared with your office
• Experienced infusion team trained in IL-23 biologics
• ACHC-accredited safety and compliance protocols

To refer a patient for Skyrizi IV therapy in Miami, contact referrals@clearwellinfusion.com or call 305‑306‑7147.

Looking to start your Skyrizi treatment at Clearwell Infusion Centers?

Fill out the form below and a member of our team will contact you